NGENF 财务： NervGen Pharma Corp. AI 分析

Q: 技术分析指标如何适用于 NGENF？

根据技术分析，NervGen Pharma Corp. 的综合信号为 Buy。NervGen Pharma Corp. 有 3 个买入信号，2 个中性信号和 2 个卖出信号。

Q: NGENF 的斐波那契回调水平是多少？

NervGen Pharma Corp. 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: NervGen Pharma Corp. 的 RSI 是多少？

NervGen Pharma Corp. 的 RSI 目前为 43.49，表明处于 中立 状态

Q: NervGen Pharma Corp. 接下来 12 个月的价格是多少？

NervGen Pharma Corp. NGENF 接下来 12 个月的价格预计为 $5.6。

Q: NervGen Pharma Corp. 预计会涨到多高？

据华尔街分析师称，NervGen Pharma Corp. 预计将达到 $7.36 的高预测值。

主页

股票

NGENF

预测

NGENF 股票价格预测

NervGen Pharma Corp.

$5.22

0.19%

$0

收盘价：Jan 23, 16:00:00 GMT-5

$5.22

盘后：Jan 23, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$5.21

开盘价

$5.25

当日区间

$5.11 - $5.38

52周范围

$1.5 - $6.3

交易量

62.4K

平均成交量

141.6K

每股收益（TTM）

-0.26

股息收益率

市值

$413.4M

什么是 NervGen Pharma Corp.？

NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for NGENF in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $5.6. The lowest target is $3.65 and the highest is $7.36. Empower your investment choices with our cutting-edge, data-driven analysis!

NGENF 股价预测摘要

NGENF的顶级分析师评级

基于 8 位分析师对 NGENF 的股票评级，更新于 Nov 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NGENF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NGENF is a Buy candidate.

NGENF stock price ended at $5.22 on 星期四, after rising 0.19%

On the latest trading day Jan 22, 2026, the stock price of NGENF rose by 0.19%, climbing from $5.25 to $5.22. Throughout the session, the stock experienced a volatility of 5.08%, with prices fluctuating between a daily low of $5.12 and a high of $5.38. Alongside this price increase, trading volume also rose by 66.3K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 62.9K shares were traded, amounting to a market value of approximately $413.4M.

NGENF 技术面信号

技术面信号摘要

购买信号 3

中性信号 2

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

NGENF目前显示3个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为0.19%。总体而言，技术指标显示中期前景为Buy。

NGENF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 NGENF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 NGENF？



NGENF 的斐波那契回调水平是多少？



NervGen Pharma Corp. 的 RSI 是多少？



NervGen Pharma Corp. 接下来 12 个月的价格是多少？



NervGen Pharma Corp. 预计会涨到多高？



NervGen Pharma Corp.（NGENF）价格

NGENF 股价走势图